Despite upbeat economic data, the markets closed lower with the Dow tumbling 69 points to 9974 as the euro dropped. Nasdaq fell 15 points to 2195.
On the upside
Neurocrine Biosciences (Nasdaq: NBIX) stock surged for a second after the company reported upbeat results from a midstage clinical trial of its endometriosis treatment elagolix.
Rodman & Renshaw (Nasdaq: RODM) will repurchase up to $5 million worth of stock.
Dycom Industries (NYSE: DY) reported lower third quarter earnings but the results topped analyst estimates.
On the downside
